- Previous Close
0.0350 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0700 - Volume
0 - Avg. Volume
154,935 - Market Cap (intraday)
3.602M - Beta (5Y Monthly) -4.05
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Diagnamed Holdings Corp., a digital health artificial intelligence company, engages in the development and commercialization of digital therapeutics for people suffering from mental health and neurological disorders. It focuses on CERVAI, a brain health AI platform; and Health GenAI, a suite of generative AI solutions for the healthcare market that includes OpenAI's ChatGPT. The company also develops Dr. GENAI, a personal AI medical chatbot designed to give people to obtain fast and personalized medical information based on a person's unique medical condition. In addition, the company developing Brain Age, an electroencephalogram-based (EEG) machine-learning solution to detect an individual's brain age for use in clinic and at-home. It has a collaboration agreement with EIREX technology for the development and commercialization of EIREX's novel modular carbon-free technology that extracts hydrogen from water. The company is headquartered in Toronto, Canada.
www.diagnamed.com--
Full Time Employees
September 30
Fiscal Year Ends
Sector
Industry
Recent News: DMED.CN
View MorePerformance Overview: DMED.CN
Trailing total returns as of 1/3/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DMED.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DMED.CN
View MoreValuation Measures
Market Cap
3.60M
Enterprise Value
3.43M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
8.05
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-92.22%
Return on Equity (ttm)
-292.41%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-610.02k
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
172.5k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-580.13k